 NEW YORK--BUSINESS WIRE--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Rafael Holdings, Inc. Holdings NYSE: RFL and Rafael Pharmaceuticals, Inc. Pharma is fair to Holdings shareholders. In connection with the proposed merger, Pharma shareholders will receive Holdings Class B common stock amounting to approximately 48 of the currently outstanding capitalization of the company. Additional equity in the company is expected to be issued in 